PMC:7335697 / 8687-10357 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T71 0-102 Sentence denotes Among 19 centres from seven European countries involved in the study, 12 registered at least one case.
T72 103-298 Sentence denotes Of the 11 790 liver transplant recipient in regular follow-up overall, 91 patients were reported, of whom 57 were classified as confirmed cases and considered for statistical analysis (figure 1).
T73 299-393 Sentence denotes Overall, 40 recipients (70%) were male and median age (IQR) at diagnosis was 65 (57–70) years.
T74 394-518 Sentence denotes Mean body mass index (BMI, kg/m2) was 26.0±4.6, with 23 (43%) and 8 (14%) patients being overweight and obese, respectively.
T75 519-641 Sentence denotes Eleven (19%) and 21 (37%) subjects were defined as very short-term and very long-term transplant recipients, respectively.
T76 642-820 Sentence denotes Additionally, median time (IQR) from transplant to COVID-19 diagnosis was 6 (2–13) years, and 32 (56%) patients had been transplanted more than 5 years before COVID-19 diagnosis.
T77 821-940 Sentence denotes Characteristics related to indication for liver transplantation and underlying liver disease are summarised in table 1.
T78 941-1070 Sentence denotes With regard to comorbidities, 21 (37%) and 10 (18%) patients had one and more than one cardiovascular (CV) disease, respectively.
T79 1071-1223 Sentence denotes In terms of CV risk factors, 32 (56%) recipients had arterial hypertension, and 21 (37%) diabetes mellitus, while 7 (12%) were active or former smokers.
T80 1224-1274 Sentence denotes Sixteen (28%) patients had chronic kidney disease.
T81 1275-1420 Sentence denotes Furthermore, 24 (42%) subjects had a clinical history of neoplasia (20 with hepatocellular carcinoma (HCC)), which was active in 5 (9%) patients.
T82 1421-1486 Sentence denotes Concomitant respiratory diseases were found in 13 (23%) patients.
T83 1487-1521 Sentence denotes Only one patient was HIV positive.
T84 1522-1670 Sentence denotes Concerning pharmacological therapy for CV prevention, 13 (23%) recipients were on ACE inhibitors or sartans, while 9 (16%) were on low-dose aspirin.